Loading...

Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab

BACKGROUND: Management of disease-modifying therapies in Multiple Sclerosis (MS) during the COVID-19 pandemic is a controversial issue. Alemtuzumab is an immunosuppressive drug that induces lymphocytes depletion. In this study, we aimed to evaluate the frequency and severity of COVID-19 in a case se...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mult Scler Relat Disord
Main Authors: Matías-Guiu, Jorge, Montero-Escribano, Paloma, Pytel, Vanesa, Porta-Etessam, Jesús, Matias-Guiu, Jordi A.
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier B.V. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7286822/
https://ncbi.nlm.nih.gov/pubmed/32554284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102297
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!